[1]王 凡,胡晓洁,陈 宇,等.海南省心血管疾病经济负担研究[J].卫生经济研究,2022,39(11):73-76.
 WANG Fan,HU Xiaojie,CHEN Yu,et al.Study on the Economic Burden of Cardiovascular Disease in Hainan Province[J].Journal Press of Health Economics Research,2022,39(11):73-76.
点击复制

海南省心血管疾病经济负担研究
分享到:

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
39
期数:
2022年11期
页码:
73-76
栏目:
疾病经济负担
出版日期:
2022-10-26

文章信息/Info

Title:
Study on the Economic Burden of Cardiovascular Disease in Hainan Province
作者:
王 凡1胡晓洁1陈 宇2顾诗宇1王润奇1刘春平1
1.海南医学院,海南 海口 571199
2.海南省卫生健康委员会,海南 海口 570203
Author(s):
WANG Fan HU Xiaojie CHEN Yu GU Shiyu WANG Runqi LIU Chunping
Hainan Medical College, Haikou Hainan 571199, China
关键词:
心血管疾病疾病经济负担医疗费用
Keywords:
cardiovascular diseases economic burden of disease medical expenses
分类号:
R19
文献标志码:
A
摘要:
目的:测算海南省心血管疾病患者的经济负担并分析其影响因素,为政策制定提供参考依据。方法:利用海南省2019年卫生总费用核算数据,计算心血管疾病经济负担;利用多元回归模型对患者门诊及住院费用的影响因素进行分析。结果:2019年海南省心血管疾病的直接经济负担7.22亿元,间接经济负担1.93亿元;药占比、机构级别、有无医保对门诊费用存在显著影响,药占比、是否手术、住院天数及机构级别对住院费用存在显著影响。结论:持续优化医疗处方行为,降低药占比;加强老年人心脑血管疾病的预防与控制;合理减少住院时间,推进分级诊疗;建立完善统一的疾病负担评价指标库,降低患者整体疾病经济负担。
Abstract:
Objective To measure the economic burden of cardiovascular disease patients in Hainan Province and analyze its influencing factors, so as to provide a reference basis for policy formulation. Methods The economic burden of cardiovascular diseases was calculated using the 2019 total health cost accounting data of Hainan Province. The influencing factors of patients' outpatient and inpatient costs were analyzed using multiple regression models. Results The direct economic burden of cardiovascular diseases in Hainan Province in 2019 was RMB 722 million, and the indirect economic burden was RMB 193 million. There were significant effects of drug occupancy ratio, institution level and type of medical insurance on outpatient costs, and significant effects of whether surgery was performed, days of hospitalization and institution level on inpatient costs. Conclusion It is suggested to continuously optimize medical prescription behaviors to reduce the drug occupancy ratio, strengthen the prevention and control of cardiovascular and cerebrovascular diseases in the elderly, reasonably reduce the length of hospitalization and promote graded treatment, and establish and improve a unified database of disease burden evaluation indicators to reduce the overall economic burden of disease on patients..

参考文献/References:

[1] 郭瑞,王增武.我国常见心血管疾病的流行现状及人群干预效果[J].中华心血管病杂志,2014,42(4):357-360.
[2] 中国心血管病风险评估和管理指南编写联合委员会.中国心血管病风险评估和管理指南[J].中国循环杂志, 2019,34(1):4-28.
[3] 张丙银,唐俊利,鹿子龙,等.山东省各地市心血管疾病负担现状及应对情况评价[J].中国慢性病预防与控制,2021,29(9):660-664.
[4] 蒙家嘉,李辉,王永,等.2009—2018年宁波市居民心血管疾病死亡及早死所致疾病负担趋势分析[J].预防医学,2021,33(5):451-456.
[5] 张绩琼,闫玉九,衡旭华,等.2017—2019年攀枝花市某医院心血管疾病住院患者疾病谱及住院费用分析[J].华南预防医学,2021,47(3):288-291.
[6] 黎倩欣,周尚成,陈飘飘,等.深圳市糖尿病疾病经济负担研究[J].卫生经济研究,2021,38(3):63-66.
[7] 王媛,曹新西,侯亚冰,等.1990和2017年中国与全球心血管病疾病负担研究[J].中国慢性病预防与控制,2020,28(1):10-13,19.
[8] 明星宇,杨练,孙群,等.四川省糖尿病疾病经济负担及影响因素分析[J].卫生经济研究,2019,36(1):29-31,37.
[9] 孙艳,李伟,尹文强,等.潍坊市老年人慢性病健康素养及影响因素分析[J].中国卫生事业管理,2020,37(11):848-852.
[10] Quentin W,Geissler A,Scheller -Kreinsen D,et al. DRG -typehospital payment in Germany:The G -DRG system[J].EuroObserver,2010,12(3): 4-6.
[11] Ma T T,Wong I C K,Man K K C,et al.Effect of evidence-based therapy for secondary prevention of cardiovascular disease:Systematic review and meta-analysis [J].PLo S One,2019, 14(1):210988.

相似文献/References:

[1]于保荣,许 晴,刘 卓,等.新发传染病经济负担的方法学研究[J].卫生经济研究,2017,(07):25.
[2]王晓茹,李银山,王 瑶,等.宁南地区新农合大病患者医疗费用负担分析[J].卫生经济研究,2017,(10):30.
[3]于保荣,冯映雪,江陈庆,等.肿瘤疾病经济负担与健康保险政策研究[J].卫生经济研究,2018,(04):14.
[4]冷 瑶,李燕喃,邓 晶.我国中老年糖尿病患者的疾病经济负担分析[J].卫生经济研究,2018,(10):47.
 LENG Yao,LI Yan-nan,DENG Jing.Analysis of the Economic Burden of Diseases in Middle-aged and Elderly Patients with Diabetes in China[J].Journal Press of Health Economics Research,2018,(11):47.
[5]明星宇,杨 练,孙 群,等.四川省糖尿病疾病经济负担及影响因素分析[J].卫生经济研究,2019,(01):29.
 MING Xing-yu,YANG Lian,SUN Qun,et al.The Disease Economic Burden and Influence of Diabetes in Sichuan Province[J].Journal Press of Health Economics Research,2019,(11):29.
[6]董 辉,汤质如,严 训,等.安徽省恶性肿瘤治疗费用分析——基于“卫生费用核算体系2011”[J].卫生经济研究,2021,38(2):58.
 DONG Hui,TANG Zhi-ru,YAN Xun,et al.Analysis on Malignant Tumor Treatment Cost in Anhui Province——Based on the SHA 2011[J].Journal Press of Health Economics Research,2021,38(11):58.
[7]黎倩欣,周尚成,陈飘飘,等.深圳市糖尿病疾病经济负担研究[J].卫生经济研究,2021,38(3):63.
 LI Qian-xin,ZHOU Shang-cheng,CHEN Piao-piao,et al.Study on the Economic Burden of Diabetic Diseases in Shenzhen[J].Journal Press of Health Economics Research,2021,38(11):63.
[8]王佳卉,马增香.多囊卵巢综合征及其并发症的直接经济负担研究进展[J].卫生经济研究,2022,39(3):24.
 WANG Jia-hui,MA Zeng-xiang.Research Progress on Direct Economic Burden of Polycystic Ovary Syndrome and Its Complications[J].Journal Press of Health Economics Research,2022,39(11):24.
[9]李福明,夏 宇,魏 艳,等.晚期非小细胞肺癌初治患者的直接非医疗成本分析[J].卫生经济研究,2022,39(10):58.
 LI Fuming,XIA Yu,WEI Yan,et al.Analysis of Direct Non-medical Cost of Newly Treated Advanced Non-small Cell Lung Cancer Patients[J].Journal Press of Health Economics Research,2022,39(11):58.
[10]李 阳,杨珂馨,宋 伟,等.高血压患者住院费用变化及影响因素分析[J].卫生经济研究,2024,41(03):65.
 LI Yang,YANG Kexin,SONG Wei,et al.Study on Changing Trend and Influencing Factors of the Hospitalization Expenses of Hypertensive Patients[J].Journal Press of Health Economics Research,2024,41(11):65.

更新日期/Last Update: 2022-10-26